Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Vituro Health is a U.S. healthcare services company focused on comprehensive prostate care, including diagnosis support, care navigation, and treatment delivery centered on high-intensity focused ultrasound (HIFU) for prostate cancer. The company built a network-based model working with physicians and hospitals to bring minimally invasive prostate cancer treatment to patients. Vituro was founded in 2015 and operated from Birmingham, Alabama under the leadership of founder and CEO Clete Walker. In April 2024, HIFU Prostate Services acquired certain HIFU assets of Vituro Health, reflecting the strategic value of Vituro's physician relationships and hospital contracts. Vituro is best characterized as a specialty men's health and prostate-care services company rather than a drug-development biotech.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Vituro Health.